Albumin based nanoparticles loaded with lapatinib (triple negative breast cancer and HER2-positive breast cancer), gemcitabine (pancreatic cancer), siRNAs (breast and lung cancers), gold nanoparticles for NSCLC, photosensitizers are also being developed [71,72,73,74,75,76,77]. This evidence concerns the gene ALB and non-small cell lung carcinoma.